(Q47758286)

5 February 2018

title

Comparison of busulfan and cyclophosphamide in the treatment of chronic myelocytic leukemia (English)

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

20 March 2023

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

20 March 2023

author name string

D. T. Kaung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4927347

20 March 2023

H. P. Close

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4927347

20 March 2023

R. M. Whittington

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4927347

20 March 2023

M. E. Patno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4927347

20 March 2023

language of work or name

English

0 references

publication date

1 March 1971

1 reference

5 February 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

20 March 2023

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

20 March 2023

1 reference

5 February 2018

volume

27

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

608-612

1 reference

5 February 2018

COMPARISON OF CYCLOPHOSPHAMIDE (CYTOXAN AND URACIL MUSTARD (U-8344) IN CHRONIC GRANULOCYTIC LEUKEMIA

cites work

1

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

Myleran in chronic myeloid leukaemia; results of treatment

20 March 2023

2

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

[First experience in treating malignant tumors with a new nitrogen mustard-phosphamidester.]

20 March 2023

3

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

Myleran in chronic myeloid leukaemia; chemical constitution and biological action

20 March 2023

5

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

The use of myleran in the treatment of chronic myelocytic leukemia

20 March 2023

6

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

Myleran therapy in malignant neoplastic disease; use of 1,4-dimethanesulfonyloxbutane with emphasis on chronic granulocytic leukemia

20 March 2023

8

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

Treatment of chronic granulocytic leukemia with 1, 4-dimethanesulfonyloxybutane (myleran)

20 March 2023

11

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

Cyclophosphamide. A clinical study

20 March 2023

12

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

Treatment of chronic granulocytic leukemia with myleran

20 March 2023

13

1 reference

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C608::AID-CNCR2820270315%3E3.0.CO;2-L

20 March 2023

Identifiers

10.1002/1097-0142(197103)27:3<608::AID-CNCR2820270315>3.0.CO;2-L

1 reference

5 February 2018

1 reference

5 February 2018